CBS Removes Trans Mandates From Its Reporting; NY Times Accuses War Crimes With...
Anti-ICE Protesters Try to Shame an Agent — It Backfires Spectacularly
For the Trans Activist Class, It’s All About Them
Ilhan Omar Claims ICE Isn’t Arresting Criminals. Here's Proof That She's Lying.
'The Constitution of a Deity' RFK Jr. on President Trump's Diet
Father-in-Law of Renee Good Refuses to Blame ICE, Urges Americans to Turn to...
Iranian State Media Airs a Direct Assassination Threat Against President Trump
US Halts Immigrant Visas From 75 Countries Over Welfare Abuse Concerns
Tricia McLaughlin Defends ICE's Visible Presence
California Man Pleads Guilty to Laundering Over $1.5M and Evading Taxes on $4M
Venezuelan Man Shot After Assaulting ICE Agent With Shovel
House Committee IT Staffer Charged With Stealing 240 Government Phones Worth $150K
Justice Department Challenges Minnesota’s Affirmative Action Hiring Requirements
Founder of LGBTQ+ Nonprofit Casa Ruby Sentenced in Federal Fraud Case
DC Rapper 'Taliban Glizzy' Sentenced to Over 18 Years for Multi-State Jewelry Heists
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos